Moneycontrol
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Strides Shasun

Strides Shasun

BSE: 532531|NSE: STAR|ISIN: INE939A01011|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Feb 22, 16:00
685.65
-14.6 (-2.08%)
VOLUME 19,494
LIVE
NSE
Feb 22, 15:58
681.20
-17.2 (-2.46%)
VOLUME 811,336
News on Strides Shasun
Select Year: 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Remain invested in Strides Shasun: Shahina Mukadam 

3.17 pm | 21 Feb 2018 |  Source: CNBC-TV18

Shahina Mukadam, Independent Market Expert is of the view that one may remain invested in Strides Shasun....

News highlights of the day: State of Emergency declared in Maldives for 15 days as protests continue

11.25 am | 05 Feb 2018 |  Source: Moneycontrol.com

This blog will keep track of key global and local developments impacting business and markets through the day. Important local and global political de...

Strides Shasun receives USFDA approval for Nystatin and Triamcinolone Acetonide Ointment

10.38 am | 31 Jan 2018 |  Source: Moneycontrol.com

Strides Shasun's wholly owned subsidiary Strides Pharma Global Pte. Limited has received approval for Nystatin and Triamcinolone Acetonide Ointmen...

News Highlights: Offshore India funds, ETFs pump in $6.5 bn in 2017

7.11 am | 31 Jan 2018 |  Source: Moneycontrol.com

This blog will keep track of key global and local developments impacting business and markets through the day. Important local and global political de...

News highlights of the day: Bitcoin armed robbery reports emerge from Britain

2.30 pm | 29 Jan 2018 |  Source: Moneycontrol.com

This blog will keep track of key global and local developments impacting business and markets through the day. Important local and global political de...

Strides Shasun arm gets USFDA nod for HIV drug

11.51 am | 29 Jan 2018 |  Source: PTI

In a BSE filing, it said Strides Pharma Global Pte. has received approval from the United States Food and Drug Administration (USFDA) for tenofovir di...

Strides Shasun gains 5% on USFDA nod for Tenofovir that treats HIV, hepatitis B infection 

11.13 am | 29 Jan 2018 |  Source: Moneycontrol.com

Tenofovir Disoproxil Fumarate tablet is a generic version of Gilead's Viread tablet, for which the patent expired on January 25, 2018....

Strides Shasun receives USFDA approval for Tenofovir Disoproxil Fumarate tablets

9.07 am | 29 Jan 2018 |  Source: Moneycontrol.com

Strides Shsun’s wholy owned subsidiary Strides Pharma Global Pte. Has received approval for Tenofovir Disoproxil Fumarate, 300 mg from the United St...

Buy Strides Shasun; target of Rs 1200: HDFC Securities

6.22 pm | 21 Nov 2017 |  Source: Moneycontrol.com

HDFC Securities is bullish on Strides Shasun has recommended buy rating on the stock with a target price of Rs 1200 in its research report dated 21 No...

Buy Strides Shasun; target of Rs 1201: Motilal Oswal

4.15 pm | 13 Nov 2017 |  Source: Moneycontrol.com

Motilal Oswal is bullish on Strides Shasun has recommended Buy rating on the stock with a target price of Rs 1201 in its research report dated October...

Strides Shasun Q2 net profit dives 87% to Rs 10.73 cr

4.50 pm | 31 Oct 2017 |  Source: PTI

The company had posted a net profit of Rs 85.43 crore for the corresponding period of the previous fiscal, Strides Shasun said in a filing to BSE....

Australia biz expanded; rebounded strongly in India & EMs: Strides Shasun 

4.11 pm | 31 Oct 2017 |  Source: CNBC-TV18

In an interview to CNBC-TV18, Shashank Sinha, Managing Director of Strides Shasun spoke about the results and his outlook for the company....

Buy Strides Shasun; target of Rs 1300: Motilal Oswal

3.48 pm | 14 Sep 2017 |  Source: Moneycontrol.com

Motilal Oswal is bullish on Strides Shasun has recommended buy rating on the stock with a target price of Rs 1300 in its research report dated Septemb...

Buy Strides Shasun; target of Rs 1030: Axis Direct

4.49 pm | 22 Aug 2017 |  Source: Moneycontrol.com

Axis Direct is bullish on Strides Shasun has recommended buy rating on the stock with a target price of Rs 1030 in its research report dated August 18...

1 2
Quick Links for Strides Shasun
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.